首页 > 最新文献

Environmental and Molecular Mutagenesis最新文献

英文 中文
Comparative Analysis of TA102 and WP2 uvrA(pKM101) Strains in Detecting Nitrosamine Mutagens in the Enhanced Ames Test TA102与WP2 uvrA(pKM101)菌株在增强Ames试验中检测亚硝胺类诱变物的比较分析
IF 2.3 4区 医学 Q3 ENVIRONMENTAL SCIENCES Pub Date : 2025-06-08 DOI: 10.1002/em.70018
Rushikesh M. Shukla, Darshan T. Valani, Chetan K. Kajavadara, Satyam N. Patel, Rajesh J. Patel, Laxit K. Bhatt, Rajesh Sundar, Mukul R. Jain

The Ames test is a fundamental assay for evaluating chemical mutagenicity, particularly for nitrosamines, which are widespread environmental and pharmaceutical contaminants. To improve sensitivity, regulatory agencies have endorsed the enhanced Ames test (EAT), which incorporates five tester strains, a 30-min pre-incubation step, and metabolic activation using both rat and hamster liver S9 fractions. While Salmonella typhimurium TA102 is known for its sensitivity to oxidative mutagens, its performance under EAT conditions has not been fully characterized. This study evaluated the mutagenic response of TA102 using two nitrosamine positive controls: N-nitrosodimethylamine (NDMA) and 1-cyclopentyl-4-nitrosopiperazine (CPNP). E. coli WP2 uvrA(pKM101) showed consistent mutagenic responses to both NDMA and CPNP, consistent with existing EAT data. TA102 demonstrated a robust response to NDMA but not to CPNP, suggesting limited sensitivity to certain nitrosamines. These findings support the continued use of WP2 uvrA(pKM101) in EAT protocols and highlight the limited utility of TA102 for comprehensive nitrosamine mutagenicity assessment.

Ames试验是评价化学致突变性的基本方法,特别是亚硝胺,亚硝胺是一种广泛存在的环境和药物污染物。为了提高敏感性,监管机构已经批准了增强的Ames试验(EAT),该试验包括5个试验菌株,30分钟的预孵化步骤,以及使用大鼠和仓鼠肝脏S9组分进行代谢激活。虽然鼠伤寒沙门氏菌TA102以其对氧化诱变剂的敏感性而闻名,但其在EAT条件下的表现尚未得到充分表征。本研究采用两种亚硝胺阳性对照:n -亚硝基二甲胺(NDMA)和1-环戊基-4-亚硝基哌嗪(CPNP)来评价TA102的致突变性。大肠杆菌WP2 uvrA(pKM101)对NDMA和CPNP均表现出一致的致突变反应,与现有的EAT数据一致。TA102对NDMA表现出强烈的反应,但对CPNP没有反应,表明对某些亚硝胺的敏感性有限。这些发现支持在EAT方案中继续使用WP2 uvrA(pKM101),并强调了TA102在全面亚硝胺致突变性评估中的有限效用。
{"title":"Comparative Analysis of TA102 and WP2 uvrA(pKM101) Strains in Detecting Nitrosamine Mutagens in the Enhanced Ames Test","authors":"Rushikesh M. Shukla,&nbsp;Darshan T. Valani,&nbsp;Chetan K. Kajavadara,&nbsp;Satyam N. Patel,&nbsp;Rajesh J. Patel,&nbsp;Laxit K. Bhatt,&nbsp;Rajesh Sundar,&nbsp;Mukul R. Jain","doi":"10.1002/em.70018","DOIUrl":"10.1002/em.70018","url":null,"abstract":"<div>\u0000 \u0000 <p>The Ames test is a fundamental assay for evaluating chemical mutagenicity, particularly for nitrosamines, which are widespread environmental and pharmaceutical contaminants. To improve sensitivity, regulatory agencies have endorsed the enhanced Ames test (EAT), which incorporates five tester strains, a 30-min pre-incubation step, and metabolic activation using both rat and hamster liver S9 fractions. While <i>Salmonella typhimurium</i> TA102 is known for its sensitivity to oxidative mutagens, its performance under EAT conditions has not been fully characterized. This study evaluated the mutagenic response of TA102 using two nitrosamine positive controls: <i>N</i>-nitrosodimethylamine (NDMA) and 1-cyclopentyl-4-nitrosopiperazine (CPNP). <i>E. coli</i> WP2 <i>uvr</i>A(pKM101) showed consistent mutagenic responses to both NDMA and CPNP, consistent with existing EAT data. TA102 demonstrated a robust response to NDMA but not to CPNP, suggesting limited sensitivity to certain nitrosamines. These findings support the continued use of WP2 <i>uvr</i>A(pKM101) in EAT protocols and highlight the limited utility of TA102 for comprehensive nitrosamine mutagenicity assessment.</p>\u0000 </div>","PeriodicalId":11791,"journal":{"name":"Environmental and Molecular Mutagenesis","volume":"66 5","pages":"291-297"},"PeriodicalIF":2.3,"publicationDate":"2025-06-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144247055","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mitochondria-Nuclear Crosstalk: Orchestrating mtDNA Maintenance 线粒体-核串扰:协调mtDNA维持。
IF 2.3 4区 医学 Q3 ENVIRONMENTAL SCIENCES Pub Date : 2025-05-26 DOI: 10.1002/em.70013
Ghazal Darfarin, Janice Pluth

The mitochondria (mt) and nucleus engage in a dynamic bidirectional communication to maintain cellular homeostasis, regulating energy production, stress response, and cell fate. Anterograde signaling directs mt function, while retrograde signaling conveys metabolic and stress-related changes from mt to the nucleus. Central to this crosstalk is mitochondrial DNA (mtDNA), which encodes key oxidative phosphorylation components. MtDNA integrity is preserved through quality control mechanisms, including fusion and fission dynamics, mitophagy, and nuclear-encoded DNA repair. Disruption in these pathways contributes to mt dysfunction, oxidative stress, and genetic instability—hallmarks of aging and diseases. Additionally, redox signaling and NAD+ homeostasis integrate mt and nuclear responses, modulating transcriptional programs that support mt biogenesis and stress adaptation. This review explores the molecular mechanisms coordinating mito-nuclear interactions, emphasizing their role in maintaining mtDNA integrity and cellular equilibrium. Understanding these processes provides insights into how mt dysfunction drives aging and disease, paving the way for targeted therapeutic strategies.

线粒体(mt)和细胞核参与一种动态的双向交流,以维持细胞稳态,调节能量产生、应激反应和细胞命运。顺行信号指导mt功能,而逆行信号将代谢和应激相关的变化从mt传递到细胞核。这个串音的核心是线粒体DNA (mtDNA),它编码关键的氧化磷酸化成分。MtDNA的完整性通过质量控制机制得以保存,包括融合和裂变动力学、有丝分裂和核编码DNA修复。这些通路的破坏会导致mt功能障碍、氧化应激和遗传不稳定——衰老和疾病的标志。此外,氧化还原信号和NAD+稳态整合了mt和核反应,调节了支持mt生物发生和应激适应的转录程序。本文综述了协调有丝分裂核相互作用的分子机制,强调了它们在维持线粒体dna完整性和细胞平衡中的作用。了解这些过程有助于深入了解mt功能障碍如何驱动衰老和疾病,为有针对性的治疗策略铺平道路。
{"title":"Mitochondria-Nuclear Crosstalk: Orchestrating mtDNA Maintenance","authors":"Ghazal Darfarin,&nbsp;Janice Pluth","doi":"10.1002/em.70013","DOIUrl":"10.1002/em.70013","url":null,"abstract":"<p>The mitochondria (mt) and nucleus engage in a dynamic bidirectional communication to maintain cellular homeostasis, regulating energy production, stress response, and cell fate. Anterograde signaling directs mt function, while retrograde signaling conveys metabolic and stress-related changes from mt to the nucleus. Central to this crosstalk is mitochondrial DNA (mtDNA), which encodes key oxidative phosphorylation components. MtDNA integrity is preserved through quality control mechanisms, including fusion and fission dynamics, mitophagy, and nuclear-encoded DNA repair. Disruption in these pathways contributes to mt dysfunction, oxidative stress, and genetic instability—hallmarks of aging and diseases. Additionally, redox signaling and NAD+ homeostasis integrate mt and nuclear responses, modulating transcriptional programs that support mt biogenesis and stress adaptation. This review explores the molecular mechanisms coordinating mito-nuclear interactions, emphasizing their role in maintaining mtDNA integrity and cellular equilibrium. Understanding these processes provides insights into how mt dysfunction drives aging and disease, paving the way for targeted therapeutic strategies.</p>","PeriodicalId":11791,"journal":{"name":"Environmental and Molecular Mutagenesis","volume":"66 5","pages":"222-242"},"PeriodicalIF":2.3,"publicationDate":"2025-05-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/em.70013","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144141638","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Application of Biological Modifiers to a Multiplexed, Human Cell-Based DNA Damage Assay Provides Mechanistic Information on Genotoxicity and Molecular Targets 生物修饰剂在多重人类细胞DNA损伤试验中的应用提供了遗传毒性和分子靶点的机制信息。
IF 2.3 4区 医学 Q3 ENVIRONMENTAL SCIENCES Pub Date : 2025-05-23 DOI: 10.1002/em.70017
Steven M. Bryce, Svetlana L. Avlasevich, Adam Conrad, Nikki E. Hall, Kyle Tichenor, Erica Briggs, Stephen D. Dertinger, Jeffrey C. Bemis

This laboratory has reported that the combined use of In Vitro MicroFlow and MultiFlow assays provides information regarding chemicals' genotoxic mode of action (MoA). In an effort to go beyond MoA assessments, we incorporated a panel of biological response modifiers that elicit specific effects on the assays' biomarker response profiles. This was done to pursue our hypothesis that such perturbation signatures would reveal information on clastogenic mechanisms and molecular targets. For this proof-of-concept study, we exposed TK6 cells to 20 known clastogens. Cells were exposed in 96-well plates in the presence and absence of each of four modifying agents at one optimized concentration: talazoparib (PARP inhibitor), MK-8776 (CHK1 inhibitor), AZD-7648 (DNA-PK inhibitor), or a cocktail of reactive oxygen species scavengers. In parallel, cells were also exposed to each of the test chemicals for 4 h, at which time cells were washed and allowed to recover for an additional 20 h. For each of these treatment conditions, sample processing and flow cytometric analyses were performed using standard In Vitro MicroFlow and MultiFlow procedures to measure micronuclei, γH2AX, phosphohistone-H3 (p-H3), p53 activation, and relative nuclei counts. The resulting biomarker response data were processed with PROAST benchmark dose (BMD) software, with modifying agent as a covariate. Unsupervised hierarchical clustering of the collective potency metrics for various combinations of biomarkers showed that clastogens with similar genotoxic mechanisms grouped together. Overall, this study shows that in combination with biological response modifiers, MultiFlow and In Vitro MicroFlow biomarkers can provide mechanistic insights into chemical-induced genotoxicity.

该实验室报告,体外MicroFlow和MultiFlow分析的联合使用提供了有关化学物质的基因毒性作用模式(MoA)的信息。为了超越MoA评估,我们纳入了一组生物反应修饰剂,这些修饰剂可对测定的生物标志物反应谱产生特定影响。这样做是为了追求我们的假设,即这样的扰动特征将揭示破胚机制和分子靶点的信息。在这项概念验证研究中,我们将TK6细胞暴露于20种已知的破胚原中。将细胞暴露在96孔板中,在存在或不存在四种修饰剂的情况下,以一个优化的浓度:talazoparib (PARP抑制剂),MK-8776 (CHK1抑制剂),AZD-7648 (DNA-PK抑制剂),或一种混合的活性氧清除剂。同时,细胞也暴露在每种测试化学品中4小时,在此期间,细胞被洗涤并允许额外的20小时恢复。对于每种处理条件,使用标准的In Vitro MicroFlow和MultiFlow程序进行样品处理和流式细胞术分析,以测量微核,γH2AX,磷酸化组蛋白- h3 (p-H3), p53激活和相对核计数。所得的生物标志物反应数据用PROAST基准剂量(BMD)软件处理,修饰剂作为协变量。不同生物标记物组合的集体效价指标的无监督分层聚类表明,具有相似遗传毒性机制的致裂原聚在一起。总的来说,本研究表明,与生物反应调节剂结合,MultiFlow和in Vitro MicroFlow生物标志物可以为化学诱导的遗传毒性提供机制见解。
{"title":"Application of Biological Modifiers to a Multiplexed, Human Cell-Based DNA Damage Assay Provides Mechanistic Information on Genotoxicity and Molecular Targets","authors":"Steven M. Bryce,&nbsp;Svetlana L. Avlasevich,&nbsp;Adam Conrad,&nbsp;Nikki E. Hall,&nbsp;Kyle Tichenor,&nbsp;Erica Briggs,&nbsp;Stephen D. Dertinger,&nbsp;Jeffrey C. Bemis","doi":"10.1002/em.70017","DOIUrl":"10.1002/em.70017","url":null,"abstract":"<div>\u0000 \u0000 <p>This laboratory has reported that the combined use of In Vitro MicroFlow and MultiFlow assays provides information regarding chemicals' genotoxic mode of action (MoA). In an effort to go beyond MoA assessments, we incorporated a panel of biological response modifiers that elicit specific effects on the assays' biomarker response profiles. This was done to pursue our hypothesis that such perturbation signatures would reveal information on clastogenic mechanisms and molecular targets. For this proof-of-concept study, we exposed TK6 cells to 20 known clastogens. Cells were exposed in 96-well plates in the presence and absence of each of four modifying agents at one optimized concentration: talazoparib (PARP inhibitor), MK-8776 (CHK1 inhibitor), AZD-7648 (DNA-PK inhibitor), or a cocktail of reactive oxygen species scavengers. In parallel, cells were also exposed to each of the test chemicals for 4 h, at which time cells were washed and allowed to recover for an additional 20 h. For each of these treatment conditions, sample processing and flow cytometric analyses were performed using standard In Vitro MicroFlow and MultiFlow procedures to measure micronuclei, γH2AX, phosphohistone-H3 (p-H3), p53 activation, and relative nuclei counts. The resulting biomarker response data were processed with PROAST benchmark dose (BMD) software, with modifying agent as a covariate. Unsupervised hierarchical clustering of the collective potency metrics for various combinations of biomarkers showed that clastogens with similar genotoxic mechanisms grouped together. Overall, this study shows that in combination with biological response modifiers, MultiFlow and In Vitro MicroFlow biomarkers can provide mechanistic insights into chemical-induced genotoxicity.</p>\u0000 </div>","PeriodicalId":11791,"journal":{"name":"Environmental and Molecular Mutagenesis","volume":"66 5","pages":"280-290"},"PeriodicalIF":2.3,"publicationDate":"2025-05-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/em.70017","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144127001","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Fertilized Avian Egg Fetal Liver Assays for Assessing DNA Damaging Potential of Chemicals: A Comparative Analysis With In Vitro and In Vivo Genotoxicity Assays and Rodent Carcinogenicity 用于评估化学物质DNA损伤潜力的受精卵胎儿肝试验:与体外和体内遗传毒性试验和啮齿动物致癌性的比较分析。
IF 2.3 4区 医学 Q3 ENVIRONMENTAL SCIENCES Pub Date : 2025-05-21 DOI: 10.1002/em.70016
Tetyana Kobets, Gary M. Williams

The ability to produce direct DNA damage (genotoxicity), which underlies the carcinogenicity of various chemicals, is typically evaluated in a regulatory-approved battery of in vitro tests with potential in vivo follow-up. Growing concerns for animal welfare and implementation of regulations restricting the use of animal testing necessitate the introduction of New Approach Methodologies (NAMs). The avian egg-based (in ovo) models were developed as metabolically competent NAMs capable of bioactivation, detoxication, and elimination of xenobiotics to potentially replace short-term in vivo genotoxicity assays for chemicals that are genotoxic in vitro. These models utilize avian (chicken or turkey) fetal livers for the evaluation of endpoints indicative of DNA damage produced by either direct or indirect mechanisms, the formation of nuclear DNA adducts and strand breaks. Avian embryos have genetic and morphologic resemblance to mammals and can be used for the evaluation of other endpoints including histopathology and genomic profiling. A concordance analysis of 87 and 59 chemicals assessed in the chicken and turkey models, respectively, revealed a stronger correlation with the results from in vivo genotoxicity assays (76% and 67% sensitivity, 79% and 72% specificity for chicken and turkey, respectively) compared to in vitro assays (58% and 56% sensitivity, 45% and 63% specificity for chicken and turkey, respectively). These results demonstrate that in ovo models detect the genotoxic potential of a broader range of compounds compared to in vitro assays with S9 supplementation. In conclusion, fertilized avian egg fetal liver assays offer a promising alternative to traditional in vivo genotoxicity assays.

产生直接DNA损伤(遗传毒性)的能力是各种化学品致癌性的基础,通常通过监管部门批准的一系列体外试验进行评估,并可能进行体内随访。对动物福利的日益关注和限制使用动物试验的法规的实施需要引入新方法方法(NAMs)。基于鸟蛋(in ovo)的模型被开发为具有代谢能力的NAMs,能够生物激活、解毒和消除外来生物,有可能取代对体外具有遗传毒性的化学物质进行短期体内遗传毒性测定。这些模型利用禽类(鸡或火鸡)胎儿肝脏来评估直接或间接机制产生的DNA损伤的终点,核DNA加合物的形成和链断裂。鸟类胚胎在遗传和形态上与哺乳动物相似,可用于其他终点的评估,包括组织病理学和基因组图谱。对鸡和火鸡模型中分别评估的87种和59种化学物质进行的一致性分析显示,与体外测定(鸡和火鸡的敏感性分别为76%和67%,特异性分别为79%和72%)相比,体内遗传毒性测定结果与体外测定(鸡和火鸡的敏感性分别为58%和56%,特异性分别为45%和63%)的相关性更强。这些结果表明,与体外检测S9相比,在卵模型中检测更广泛的化合物的遗传毒性潜力。总之,受精卵胎儿肝检测是传统体内遗传毒性检测的一种有希望的替代方法。
{"title":"Fertilized Avian Egg Fetal Liver Assays for Assessing DNA Damaging Potential of Chemicals: A Comparative Analysis With In Vitro and In Vivo Genotoxicity Assays and Rodent Carcinogenicity","authors":"Tetyana Kobets,&nbsp;Gary M. Williams","doi":"10.1002/em.70016","DOIUrl":"10.1002/em.70016","url":null,"abstract":"<div>\u0000 \u0000 <p>The ability to produce direct DNA damage (genotoxicity), which underlies the carcinogenicity of various chemicals, is typically evaluated in a regulatory-approved battery of in vitro tests with potential in vivo follow-up. Growing concerns for animal welfare and implementation of regulations restricting the use of animal testing necessitate the introduction of New Approach Methodologies (NAMs). The avian egg-based (<i>in ovo</i>) models were developed as metabolically competent NAMs capable of bioactivation, detoxication, and elimination of xenobiotics to potentially replace short-term in vivo genotoxicity assays for chemicals that are genotoxic in vitro. These models utilize avian (chicken or turkey) fetal livers for the evaluation of endpoints indicative of DNA damage produced by either direct or indirect mechanisms, the formation of nuclear DNA adducts and strand breaks. Avian embryos have genetic and morphologic resemblance to mammals and can be used for the evaluation of other endpoints including histopathology and genomic profiling. A concordance analysis of 87 and 59 chemicals assessed in the chicken and turkey models, respectively, revealed a stronger correlation with the results from in vivo genotoxicity assays (76% and 67% sensitivity, 79% and 72% specificity for chicken and turkey, respectively) compared to in vitro assays (58% and 56% sensitivity, 45% and 63% specificity for chicken and turkey, respectively). These results demonstrate that <i>in ovo</i> models detect the genotoxic potential of a broader range of compounds compared to in vitro assays with S9 supplementation. In conclusion, fertilized avian egg fetal liver assays offer a promising alternative to traditional in vivo genotoxicity assays.</p>\u0000 </div>","PeriodicalId":11791,"journal":{"name":"Environmental and Molecular Mutagenesis","volume":"66 5","pages":"258-279"},"PeriodicalIF":2.3,"publicationDate":"2025-05-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/em.70016","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144109742","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Applicability of In Silico New Approach Methods for the Risk Assessment of Tattoo Ink Ingredients 纹身油墨成分风险评估的计算机新方法的适用性
IF 2.3 4区 医学 Q3 ENVIRONMENTAL SCIENCES Pub Date : 2025-05-19 DOI: 10.1002/em.70010
Prachi Pradeep, Stefanie Seifert, Ajay Vikram Singh, Peter Laux, Ralph Pirow

Tattoo inks contain several substances, including organic and inorganic pigments, additives, and solvents, which may pose a health risk to not only the tattooed skin but also to other parts of the human body due to intradermal exposure. Substances in tattoo inks are regulated by entry 75 in Annex XVII of REACH Regulation (EC) No. 1907/2006. However, despite these legal requirements, a well-defined criterion for the safety assessment of tattoo inks remains lacking. In this context, 2021 BfR opinion titled “Tattoo inks: minimum requirements and test methods” proposed a comprehensive risk assessment of pigments using in vitro/in-chemico data in accordance with OECD Guidelines and CLP Regulations. In the absence of experimental data, new approach methodologies (NAMs) may be used for data-gap filling. Therefore, this work evaluates the applicability of in silico NAMs for data-gap filling for a list of tattoo ink ingredients identified by the Joint Research Centre (JRC) and BfR for genotoxicity assessment. Experimental in vitro genotoxicity data were acquired from the International Uniform Chemical Information Database (IUCLID) which makes non-confidential REACH Study Results publicly accessible. The specific aims of this analysis were the evaluation of in silico genotoxicity predictions from publicly available QSAR tools and structural alerts, the development and validation of new QSAR models specific to tattoo ink ingredients, and the application of in silico models for categorization and prioritization of data-poor ingredients for further screening. Based on the workflow developed in this study, 4 high priority, 18 medium priority, and 2 low priority substances were identified for further assessment.

纹身油墨含有多种物质,包括有机和无机颜料、添加剂和溶剂,这些物质不仅会对纹身的皮肤造成健康风险,还会因皮内接触而对人体其他部位造成健康风险。纹身油墨中的物质受REACH法规(EC) No 1907/2006附件XVII第75条的监管。然而,尽管有这些法律要求,纹身油墨的安全评估仍然缺乏一个明确的标准。在此背景下,2021年BfR题为“纹身油墨:最低要求和测试方法”的意见根据经合组织指南和CLP法规,提出了使用体外/化学数据对颜料进行全面风险评估。在缺乏实验数据的情况下,可以使用新的方法方法(NAMs)来填补数据缺口。因此,本工作评估了由联合研究中心(JRC)和BfR确定的纹身油墨成分清单的数据缺口填充的硅NAMs的适用性,用于遗传毒性评估。实验体外遗传毒性数据来自国际统一化学信息数据库(IUCLID),这使得非机密的REACH研究结果可以公开获取。该分析的具体目的是评估来自公开可用的QSAR工具和结构警报的计算机遗传毒性预测,开发和验证针对纹身油墨成分的新QSAR模型,以及应用计算机模型对数据贫乏的成分进行分类和优先级排序,以便进一步筛选。根据本研究制定的工作流程,确定了4种高优先级、18种中等优先级和2种低优先级物质供进一步评估。
{"title":"Applicability of In Silico New Approach Methods for the Risk Assessment of Tattoo Ink Ingredients","authors":"Prachi Pradeep,&nbsp;Stefanie Seifert,&nbsp;Ajay Vikram Singh,&nbsp;Peter Laux,&nbsp;Ralph Pirow","doi":"10.1002/em.70010","DOIUrl":"https://doi.org/10.1002/em.70010","url":null,"abstract":"<p>Tattoo inks contain several substances, including organic and inorganic pigments, additives, and solvents, which may pose a health risk to not only the tattooed skin but also to other parts of the human body due to intradermal exposure. Substances in tattoo inks are regulated by entry 75 in Annex XVII of REACH Regulation (EC) No. 1907/2006. However, despite these legal requirements, a well-defined criterion for the safety assessment of tattoo inks remains lacking. In this context, 2021 BfR opinion titled “Tattoo inks: minimum requirements and test methods” proposed a comprehensive risk assessment of pigments using in vitro/in-chemico data in accordance with OECD Guidelines and CLP Regulations. In the absence of experimental data, new approach methodologies (NAMs) may be used for data-gap filling. Therefore, this work evaluates the applicability of in silico NAMs for data-gap filling for a list of tattoo ink ingredients identified by the Joint Research Centre (JRC) and BfR for genotoxicity assessment. Experimental in vitro genotoxicity data were acquired from the International Uniform Chemical Information Database (IUCLID) which makes non-confidential REACH Study Results publicly accessible. The specific aims of this analysis were the evaluation of in silico genotoxicity predictions from publicly available QSAR tools and structural alerts, the development and validation of new QSAR models specific to tattoo ink ingredients, and the application of in silico models for categorization and prioritization of data-poor ingredients for further screening. Based on the workflow developed in this study, 4 high priority, 18 medium priority, and 2 low priority substances were identified for further assessment.</p>","PeriodicalId":11791,"journal":{"name":"Environmental and Molecular Mutagenesis","volume":"66 4","pages":"199-209"},"PeriodicalIF":2.3,"publicationDate":"2025-05-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/em.70010","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144091823","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Chicken Egg Genotoxicity Assay (CEGA): Assessing Target Tissue Exposure and Metabolism in the Embryo-Fetal Chicken Livers 鸡蛋遗传毒性试验(CEGA):评估鸡胚-胎肝中的靶组织暴露和代谢。
IF 2.3 4区 医学 Q3 ENVIRONMENTAL SCIENCES Pub Date : 2025-05-12 DOI: 10.1002/em.70015
Yax Thakkar, T. Kobets, Anne Marie Api, J. D. Duan, G. M. Williams

The Chicken Egg Genotoxicity Assay (CEGA) is an avian egg-based model that utilizes the livers of developing chicken embryo-fetuses to assess the ability of chemicals to produce direct DNA damage. The main goal of the study was to evaluate target tissue exposure and metabolism in the CEGA to assess its suitability as a biologically relevant new approach methodology (NAM) for detecting the genotoxic potential of chemicals. An imaging study using two-photon excitation microscopy after the administration of a fluorescent dye (acridine orange) verified that chemicals following administration into the air sac of the fertilized chicken egg reach the target organ, liver. A metabolism study using liquid chromatography with high resolution mass spectrometry (LC/MS), conducted after the administration of benzo(a)pyrene (B(a)P) according to the CEGA protocol, confirmed the formation of sufficient amounts of reactive metabolite(s) responsible for the genotoxic effects of a parent compound upon reaching the target tissue. Moreover, an RNA sequencing study revealed that B(a)P in embryo-fetal chicken livers significantly upregulated several genes responsible for the activity of the CYP1A1 enzyme, which is critical for the bioactivation of B(a)P. These findings, along with the previously reported DNA damage (i.e., DNA adducts and single-strand breaks) produced by B(a)P in CEGA, support sufficient target tissue exposure to B(a)P and the ability of avian fetal livers to bioactivate B(a)P to a reactive intermediate. Overall, the findings in the study support the conclusion that the CEGA can be considered a robust potential alternative to the animal testing strategy for assessing the genotoxic potential of chemicals.

鸡蛋遗传毒性试验(CEGA)是一种基于鸡蛋的模型,利用发育中的鸡胚胎的肝脏来评估化学物质产生直接DNA损伤的能力。该研究的主要目的是评估靶组织在CEGA中的暴露和代谢,以评估其作为检测化学物质遗传毒性潜力的生物学相关新方法方法(NAM)的适用性。在使用荧光染料(吖啶橙)后,使用双光子激发显微镜进行成像研究,证实化学物质进入受精卵的气囊后到达目标器官肝脏。根据CEGA方案,在给予苯并(A)芘(B(A)P)后,使用液相色谱和高分辨率质谱(LC/MS)进行了代谢研究,证实形成了足够数量的反应性代谢物(s),负责母体化合物到达目标组织后的遗传毒性作用。此外,一项RNA测序研究显示,鸡胚-胎肝中的B(a)P显著上调了几个负责CYP1A1酶活性的基因,而CYP1A1酶对B(a)P的生物活性至关重要。这些发现,连同先前报道的由B(a)P在CEGA中产生的DNA损伤(即DNA加合物和单链断裂),支持充分的靶组织暴露于B(a)P和禽胎儿肝脏将B(a)P生物激活为活性中间体的能力。总的来说,研究结果支持这样的结论,即CEGA可以被认为是评估化学品遗传毒性潜力的动物试验策略的一个强有力的潜在替代方案。
{"title":"The Chicken Egg Genotoxicity Assay (CEGA): Assessing Target Tissue Exposure and Metabolism in the Embryo-Fetal Chicken Livers","authors":"Yax Thakkar,&nbsp;T. Kobets,&nbsp;Anne Marie Api,&nbsp;J. D. Duan,&nbsp;G. M. Williams","doi":"10.1002/em.70015","DOIUrl":"10.1002/em.70015","url":null,"abstract":"<p>The Chicken Egg Genotoxicity Assay (CEGA) is an avian egg-based model that utilizes the livers of developing chicken embryo-fetuses to assess the ability of chemicals to produce direct DNA damage. The main goal of the study was to evaluate target tissue exposure and metabolism in the CEGA to assess its suitability as a biologically relevant new approach methodology (NAM) for detecting the genotoxic potential of chemicals. An imaging study using two-photon excitation microscopy after the administration of a fluorescent dye (acridine orange) verified that chemicals following administration into the air sac of the fertilized chicken egg reach the target organ, liver. A metabolism study using liquid chromatography with high resolution mass spectrometry (LC/MS), conducted after the administration of benzo(a)pyrene (B(a)P) according to the CEGA protocol, confirmed the formation of sufficient amounts of reactive metabolite(s) responsible for the genotoxic effects of a parent compound upon reaching the target tissue. Moreover, an RNA sequencing study revealed that B(a)P in embryo-fetal chicken livers significantly upregulated several genes responsible for the activity of the CYP1A1 enzyme, which is critical for the bioactivation of B(a)P. These findings, along with the previously reported DNA damage (i.e., DNA adducts and single-strand breaks) produced by B(a)P in CEGA, support sufficient target tissue exposure to B(a)P and the ability of avian fetal livers to bioactivate B(a)P to a reactive intermediate. Overall, the findings in the study support the conclusion that the CEGA can be considered a robust potential alternative to the animal testing strategy for assessing the genotoxic potential of chemicals.</p>","PeriodicalId":11791,"journal":{"name":"Environmental and Molecular Mutagenesis","volume":"66 5","pages":"243-257"},"PeriodicalIF":2.3,"publicationDate":"2025-05-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/em.70015","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143970973","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Adverse Outcome Pathway-Informed Integrated Testing to Identify Chemicals Causing Genotoxicity Through Oxidative DNA Damage: Case Study on 4-Nitroquinoline 1-Oxide 通过氧化DNA损伤识别化学物质引起遗传毒性的不良结果通路知情综合测试:4-硝基喹啉1-氧化物的案例研究。
IF 2.3 4区 医学 Q3 ENVIRONMENTAL SCIENCES Pub Date : 2025-05-08 DOI: 10.1002/em.70011
Elizabeth Huliganga, Eunnara Cho, Carol D. Swartz, Andrew Williams, Leslie Recio, Jesse J. Salk, Francesco Marchetti, Carole L. Yauk

Adverse outcome pathways (AOPs) provide a framework to organize and weigh evidence linking molecular interactions of toxicants in cells to adverse outcomes relevant to risk assessment or regulatory decision-making. Applying this framework facilitates the interpretation of data produced using new test methods. We used an existing AOP (AOP #296) that describes how oxidative DNA damage leads to mutations and chromosomal aberrations to develop an integrated testing strategy to evaluate whether a chemical operates through this pathway. We exposed human TK6 cells to increasing concentrations of 4-nitroquinoline 1-oxide (4NQO), a tobacco mimetic that causes oxidative DNA damage, in a time-series design. We measured oxidative DNA damage and strand breaks using the high-throughput CometChip assay with and without formamidopyrimidine DNA glycosylase (Fpg), alongside analyses of micronucleus (MN) frequency by flow cytometry, and mutations by error-corrected sequencing (duplex sequencing—DS). Our analysis shows how these methods can be combined to quantify 4NQO-induced, concentration- and time-dependent increases in: (a) oxidative DNA damage (occurred early and at low concentrations); (b) strand breaks (remained elevated to 6 h post-exposure); (c) MN frequency (at 24 h); (d) mutation frequency (at 48 h); and (e) C > A transversions consistent with expected substitutions induced by oxidative DNA lesions. The time series shows the repair of oxidative DNA damage with persistent strand breaks remaining at 6 h. Overall, we provide an example of an AOP-informed testing strategy and contribute to the quantitative understanding of AOP #296. We also demonstrate the value of DS as an effective approach for mutagenicity assessment.

不良后果途径(AOPs)提供了一个框架,用于组织和权衡细胞中毒物分子相互作用与风险评估或监管决策相关的不良后果之间的证据。应用此框架有助于解释使用新测试方法产生的数据。我们使用现有的AOP (AOP #296)描述了氧化DNA损伤如何导致突变和染色体畸变,以开发一个综合测试策略来评估化学物质是否通过该途径起作用。我们在时间序列设计中将人类TK6细胞暴露于浓度不断增加的4-硝基喹啉1-氧化物(4NQO)中,这是一种引起氧化性DNA损伤的烟草模拟物。我们使用高通量CometChip测定氧化DNA损伤和链断裂,使用和不使用甲酰胺嘧啶DNA糖基酶(Fpg),同时通过流式细胞术分析微核(MN)频率,并通过错误校正测序(双工测序- ds)分析突变。我们的分析显示了如何将这些方法结合起来量化4nqo诱导的浓度和时间依赖性增加:(a)氧化DNA损伤(发生在早期和低浓度下);(b)链断裂(暴露后6小时仍保持升高);(c) MN频率(24 h);(d)突变频率(48 h);(e)与氧化DNA损伤引起的预期取代一致的C > A转换。时间序列显示氧化DNA损伤的修复,持续的链断裂在6小时后仍然存在。总之,我们提供了一个基于AOP的测试策略示例,并有助于对AOP #296的定量理解。我们还证明了DS作为一种有效的致突变性评估方法的价值。
{"title":"Adverse Outcome Pathway-Informed Integrated Testing to Identify Chemicals Causing Genotoxicity Through Oxidative DNA Damage: Case Study on 4-Nitroquinoline 1-Oxide","authors":"Elizabeth Huliganga,&nbsp;Eunnara Cho,&nbsp;Carol D. Swartz,&nbsp;Andrew Williams,&nbsp;Leslie Recio,&nbsp;Jesse J. Salk,&nbsp;Francesco Marchetti,&nbsp;Carole L. Yauk","doi":"10.1002/em.70011","DOIUrl":"10.1002/em.70011","url":null,"abstract":"<p>Adverse outcome pathways (AOPs) provide a framework to organize and weigh evidence linking molecular interactions of toxicants in cells to adverse outcomes relevant to risk assessment or regulatory decision-making. Applying this framework facilitates the interpretation of data produced using new test methods. We used an existing AOP (AOP #296) that describes how oxidative DNA damage leads to mutations and chromosomal aberrations to develop an integrated testing strategy to evaluate whether a chemical operates through this pathway. We exposed human TK6 cells to increasing concentrations of 4-nitroquinoline 1-oxide (4NQO), a tobacco mimetic that causes oxidative DNA damage, in a time-series design. We measured oxidative DNA damage and strand breaks using the high-throughput CometChip assay with and without formamidopyrimidine DNA glycosylase (Fpg), alongside analyses of micronucleus (MN) frequency by flow cytometry, and mutations by error-corrected sequencing (duplex sequencing—DS). Our analysis shows how these methods can be combined to quantify 4NQO-induced, concentration- and time-dependent increases in: (a) oxidative DNA damage (occurred early and at low concentrations); (b) strand breaks (remained elevated to 6 h post-exposure); (c) MN frequency (at 24 h); (d) mutation frequency (at 48 h); and (e) C &gt; A transversions consistent with expected substitutions induced by oxidative DNA lesions. The time series shows the repair of oxidative DNA damage with persistent strand breaks remaining at 6 h. Overall, we provide an example of an AOP-informed testing strategy and contribute to the quantitative understanding of AOP #296. We also demonstrate the value of DS as an effective approach for mutagenicity assessment.</p>","PeriodicalId":11791,"journal":{"name":"Environmental and Molecular Mutagenesis","volume":"66 4","pages":"185-198"},"PeriodicalIF":2.3,"publicationDate":"2025-05-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/em.70011","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143970486","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Aflatoxin B1-Induced Hepatic Mutagenesis in Mice Expressing Gene-Edited Neil1 黄曲霉毒素b1诱导表达基因编辑Neil1的小鼠肝脏突变
IF 2.3 4区 医学 Q3 ENVIRONMENTAL SCIENCES Pub Date : 2025-05-08 DOI: 10.1002/em.70014
Irina G. Minko, Vladimir L. Vartanian, Michael M. Luzadder, Yingming Wang, Lev M. Fedorov, Amanda K. McCullough, R. Stephen Lloyd

Hepatocellular carcinoma (HCC) remains one of the leading causes of cancer-associated mortality, correlating with obesity, alcohol consumption, hepatitis B and C infections, and dietary exposure to aflatoxin B1 (AFB1). The etiology of AFB1-induced HCC involves the formation of highly mutagenic guanine lesions that can be repaired by a branch of the base excision repair pathway initiated by the DNA glycosylase, NEIL1. In a murine model, NEIL1 deficiency results in increased AFB1-induced mutagenesis and carcinogenesis. Previous analyses identified several defective NEIL1 variants in human populations, including the temperature-sensitive A51V and glycosylase-deficient G83D variants. Herein, we report AFB1-induced mutagenesis in mice expressing the A51V and G83D NEIL1 variants. Cohorts of 6-day-old Neil1A51V and Neil1G83D homozygous mice were injected with a single dose of AFB1, and frequencies and spectra of mutations were assessed in liver genomes 2.5 months post-exposure using duplex sequencing. Comparisons of these data with previously generated data on AFB1-induced mutagenesis in wild-type (WT) and Neil1−/− mice revealed that although mutation frequencies in Neil1A51V and Neil1G83D animals were comparable to those measured in WT, elevated proportions of base substitutions at A/T sites were consistent with NEIL1 deficiency in both of these models. These findings suggest that individuals carrying these NEIL1 variants could be at an elevated risk for the development of AFB1-induced HCC.

肝细胞癌(HCC)仍然是癌症相关死亡的主要原因之一,与肥胖、饮酒、乙型和丙型肝炎感染以及饮食中接触黄曲霉毒素B1 (AFB1)有关。afb1诱导的HCC的病因涉及高度诱变的鸟嘌呤病变的形成,这些病变可以通过DNA糖基化酶NEIL1启动的碱基切除修复途径的一个分支进行修复。在小鼠模型中,NEIL1缺乏导致afb1诱导的突变和癌变增加。先前的分析在人群中发现了几种有缺陷的NEIL1变体,包括温度敏感的A51V和糖基酶缺陷的G83D变体。在此,我们报道了afb1诱导表达A51V和G83D NEIL1变异的小鼠发生突变。将6日龄的Neil1A51V和Neil1G83D纯合子小鼠注射单剂量AFB1,并在暴露2.5个月后使用双工测序评估肝脏基因组突变的频率和谱。将这些数据与先前在野生型(WT)和Neil1-/-小鼠中产生的afb1诱变数据进行比较发现,尽管Neil1A51V和Neil1G83D动物的突变频率与在WT中测量的频率相当,但在这两种模型中,A/T位点碱基置换比例升高与Neil1缺乏一致。这些发现表明,携带这些NEIL1变异的个体发生afb1诱导的HCC的风险可能更高。
{"title":"Aflatoxin B1-Induced Hepatic Mutagenesis in Mice Expressing Gene-Edited Neil1","authors":"Irina G. Minko,&nbsp;Vladimir L. Vartanian,&nbsp;Michael M. Luzadder,&nbsp;Yingming Wang,&nbsp;Lev M. Fedorov,&nbsp;Amanda K. McCullough,&nbsp;R. Stephen Lloyd","doi":"10.1002/em.70014","DOIUrl":"10.1002/em.70014","url":null,"abstract":"<div>\u0000 \u0000 <p>Hepatocellular carcinoma (HCC) remains one of the leading causes of cancer-associated mortality, correlating with obesity, alcohol consumption, hepatitis B and C infections, and dietary exposure to aflatoxin B<sub>1</sub> (AFB<sub>1</sub>). The etiology of AFB<sub>1</sub>-induced HCC involves the formation of highly mutagenic guanine lesions that can be repaired by a branch of the base excision repair pathway initiated by the DNA glycosylase, NEIL1. In a murine model, NEIL1 deficiency results in increased AFB<sub>1</sub>-induced mutagenesis and carcinogenesis. Previous analyses identified several defective NEIL1 variants in human populations, including the temperature-sensitive A51V and glycosylase-deficient G83D variants. Herein, we report AFB<sub>1</sub>-induced mutagenesis in mice expressing the A51V and G83D NEIL1 variants. Cohorts of 6-day-old <i>Neil1</i><sup><i>A51V</i></sup> and <i>Neil1</i><sup><i>G83D</i></sup> homozygous mice were injected with a single dose of AFB<sub>1</sub>, and frequencies and spectra of mutations were assessed in liver genomes 2.5 months post-exposure using duplex sequencing. Comparisons of these data with previously generated data on AFB<sub>1</sub>-induced mutagenesis in wild-type (WT) and <i>Neil1</i><sup><i>−/−</i></sup> mice revealed that although mutation frequencies in <i>Neil1</i><sup><i>A51V</i></sup> and <i>Neil1</i><sup><i>G83D</i></sup> animals were comparable to those measured in WT, elevated proportions of base substitutions at A/T sites were consistent with NEIL1 deficiency in both of these models. These findings suggest that individuals carrying these NEIL1 variants could be at an elevated risk for the development of AFB<sub>1</sub>-induced HCC.</p>\u0000 </div>","PeriodicalId":11791,"journal":{"name":"Environmental and Molecular Mutagenesis","volume":"66 4","pages":"144-154"},"PeriodicalIF":2.3,"publicationDate":"2025-05-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143987432","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Using N-Nitrosodiethanolamine (NDELA) and N-Nitrosopiperidine (NPIP) Transgenic Rodent Gene Mutation Data and Quantum Mechanical Modeling to Derive Potency-Based Acceptable Intakes for NDSRIs Lacking Robust Carcinogenicity Data 利用n -亚硝基二乙醇胺(NDELA)和n -亚硝基sopiperidine (NPIP)转基因啮齿动物基因突变数据和量子力学模型,得出缺乏可靠致癌性数据的NDSRIs的基于效价的可接受摄入量。
IF 2.3 4区 医学 Q3 ENVIRONMENTAL SCIENCES Pub Date : 2025-05-08 DOI: 10.1002/em.70012
Jason M. Roper, Troy R. Griffin, George E. Johnson, Jakub Kostal, Raphael Nudelman, Gregory R. Ott, Adelina Voutchkova-Kostal, Valerie Niddam-Hildesheim

Acceptable intake (AI) limits for nitrosamine drug substance related impurities (NDSRIs) that lack carcinogenicity data could be estimated from mutagenic potency relative to anchor nitrosamines with carcinogenicity data. This approach integrates points of departure (PoDs) derived from in vivo mutagenicity studies with in silico predictions generated by a validated quantum-mechanical (QM) model. N-nitrosodiethanolamine (NDELA) and N-nitrosopiperidine (NPIP), with AIs derived from robust carcinogenicity data, were tested in the transgenic rodent (TGR) gene mutation assay. Liver mutant frequency and benchmark dose (BMD) modeling provided a suitable, robust, and precise PoD metric. BMD confidence intervals (CIs) calculated from mutant frequency expanded the potency range of previously reported BMD CIs for other anchor nitrosamines. Cancer-protective AIs for mutagenic NDSRIs can be pragmatically calculated on a potency basis by comparing their lower bound TGR BMD CIs with the BMD CIs and AIs derived from model/anchor nitrosamines that have results for in vivo gene mutation and cancer bioassays. In vivo modeling was supported by the Computer-Aided Discovery and RE-design (CADRE) program, a validated QM model for predicting NDSRI carcinogenic potency based on the underlying mechanism of mutagenicity. CADRE distinguished between anchor nitrosamines N-nitrosodiethylamine (NDEA) and N-nitrosodimethylamine (NDMA) and the less potent NDELA and NPIP. Scrutiny of underlying reactivity indices and relevant physicochemical properties rationalized the observed trend in metabolic activity and thus predicted carcinogenic potency. Leveraging the in vivo–in silico approach is valuable in gaining confidence in the proposed AIs, whereby the QM model serves as mechanistic validation of in vivo results.

缺乏致癌性数据的亚硝胺原料药相关杂质(NDSRIs)的可接受摄入量(AI)限制可以通过相对于具有致癌性数据的锚定亚硝胺的致突变效力来估计。该方法将从体内诱变研究中得出的出发点(pod)与经过验证的量子力学(QM)模型生成的计算机预测相结合。n -亚硝基二乙醇胺(NDELA)和n -亚硝基sopiperidine (NPIP)在转基因啮齿类动物(TGR)基因突变实验中进行了检测,它们具有可靠的致癌性数据。肝脏突变频率和基准剂量(BMD)模型提供了一个合适、稳健和精确的PoD度量。根据突变频率计算的BMD置信区间(CIs)扩大了先前报道的BMD CIs对其他锚定亚硝胺的效力范围。通过将致突变NDSRIs的下界TGR BMD CIs与模型/锚定亚硝胺衍生的BMD CIs和AIs进行比较,可以在效价的基础上实际计算出NDSRIs的癌症保护AIs,后者具有体内基因突变和癌症生物测定结果。体内模型由计算机辅助发现和重新设计(CADRE)程序支持,该程序是一个经过验证的QM模型,可根据致突变性的潜在机制预测NDSRI的致癌效力。CADRE区分了锚定亚硝胺n -亚硝基二乙胺(NDEA)和n -亚硝基二甲胺(NDMA)以及效力较弱的NDELA和NPIP。对潜在的反应性指数和相关的物理化学性质的仔细研究使观察到的代谢活动趋势合理化,从而预测了致癌效力。利用体内硅片方法在获得对所提议的人工智能的信心方面是有价值的,因此QM模型可以作为体内结果的机制验证。
{"title":"Using N-Nitrosodiethanolamine (NDELA) and N-Nitrosopiperidine (NPIP) Transgenic Rodent Gene Mutation Data and Quantum Mechanical Modeling to Derive Potency-Based Acceptable Intakes for NDSRIs Lacking Robust Carcinogenicity Data","authors":"Jason M. Roper,&nbsp;Troy R. Griffin,&nbsp;George E. Johnson,&nbsp;Jakub Kostal,&nbsp;Raphael Nudelman,&nbsp;Gregory R. Ott,&nbsp;Adelina Voutchkova-Kostal,&nbsp;Valerie Niddam-Hildesheim","doi":"10.1002/em.70012","DOIUrl":"10.1002/em.70012","url":null,"abstract":"<div>\u0000 \u0000 <p>Acceptable intake (AI) limits for nitrosamine drug substance related impurities (NDSRIs) that lack carcinogenicity data could be estimated from mutagenic potency relative to anchor nitrosamines with carcinogenicity data. This approach integrates points of departure (PoDs) derived from in vivo mutagenicity studies with in silico predictions generated by a validated quantum-mechanical (QM) model. <i>N</i>-nitrosodiethanolamine (NDELA) and <i>N</i>-nitrosopiperidine (NPIP), with AIs derived from robust carcinogenicity data, were tested in the transgenic rodent (TGR) gene mutation assay. Liver mutant frequency and benchmark dose (BMD) modeling provided a suitable, robust, and precise PoD metric. BMD confidence intervals (CIs) calculated from mutant frequency expanded the potency range of previously reported BMD CIs for other anchor nitrosamines. Cancer-protective AIs for mutagenic NDSRIs can be pragmatically calculated on a potency basis by comparing their lower bound TGR BMD CIs with the BMD CIs and AIs derived from model/anchor nitrosamines that have results for in vivo gene mutation and cancer bioassays. In vivo modeling was supported by the Computer-Aided Discovery and RE-design (CADRE) program, a validated QM model for predicting NDSRI carcinogenic potency based on the underlying mechanism of mutagenicity. CADRE distinguished between anchor nitrosamines <i>N</i>-nitrosodiethylamine (NDEA) and <i>N</i>-nitrosodimethylamine (NDMA) and the less potent NDELA and NPIP. Scrutiny of underlying reactivity indices and relevant physicochemical properties rationalized the observed trend in metabolic activity and thus predicted carcinogenic potency. Leveraging the in vivo–in silico approach is valuable in gaining confidence in the proposed AIs, whereby the QM model serves as mechanistic validation of in vivo results.</p>\u0000 </div>","PeriodicalId":11791,"journal":{"name":"Environmental and Molecular Mutagenesis","volume":"66 4","pages":"155-171"},"PeriodicalIF":2.3,"publicationDate":"2025-05-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144003967","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Benchmark Response (BMR) Values for In Vivo Mutagenicity Endpoints 体内诱变终点的基准反应(BMR)值。
IF 2.3 4区 医学 Q3 ENVIRONMENTAL SCIENCES Pub Date : 2025-04-04 DOI: 10.1002/em.70006
Paul A. White, Guangchao Chen, Nikolai Chepelev, Madison A. Bell, Lauren R. Gallant, George E. Johnson, Andreas Zeller, Marc A. Beal, Alexandra S. Long

The benchmark dose (BMD) approach constitutes the most effective and pragmatic strategy for the derivation of a point of departure (PoD) for comparative potency analysis, risk assessment, and regulatory decision-making. There is considerable controversy regarding the most appropriate benchmark response (BMR) for genotoxicity endpoints. This work employed the Slob (2017) Effect Size (ES) theory to define robust BMR values for the in vivo transgenic rodent (TGR) and Pig-a mutagenicity endpoints. An extensive database of dose–response data was prepared and curated; BMD analyses were used to determine endpoint-specific maxima (i.e., parameter c) and within-group variance (i.e., var). Detailed analyses investigated the dependence of var on experimental factors such as tissue, administration route, treatment duration, and post-exposure tissue sampling time. The overall lack of influence of these experimental factors on var permitted the determination of typical values for the endpoints investigated. Typical var for the TGR endpoint is 0.19; the value for the Pig-a endpoint is 0.29. Endpoint-specific var values were used to calculate endpoint-specific BMR values; the values are 47% for TGR and 60% for Pig-a. Endpoint-specific BMR values were also calculated using the trimmed distribution of study-specific standard deviation (SD) values for concurrent controls. Those analyses yielded endpoint-specific BMR values for the TGR and Pig-a endpoints of 33% and 58%, respectively. Considering the results obtained, and the in vivo genetic toxicity BMR values noted in the literature, we recommend a BMR of 50% for in vivo mutagenicity endpoints. The value can be employed to interpret mutagenicity dose–response data in a risk assessment context.

基准剂量(BMD)方法是推导起始点(PoD)以进行比较效力分析、风险评估和监管决策的最有效和实用的策略。关于遗传毒性终点的最合适基准反应(BMR)存在相当大的争议。本研究采用Slob(2017)效应大小(ES)理论定义了体内转基因啮齿动物(TGR)和猪-a致突变性终点的稳健BMR值。编制和管理了一个广泛的剂量-反应数据数据库;骨密度分析用于确定终点特定最大值(即参数c)和组内方差(即var)。详细分析了var对实验因素的依赖性,如组织、给药途径、治疗持续时间和暴露后组织采样时间。这些实验因素对var总体上没有影响,因此可以确定所研究的终点的典型值。TGR终点的典型var为0.19;Pig-a端点的值为0.29。终点特异性var值用于计算终点特异性BMR值;TGR为47%,Pig-a为60%。终点特异性BMR值也使用研究特异性标准差(SD)值的修剪分布计算。这些分析得出TGR和Pig-a的终点特异性BMR值分别为33%和58%。考虑到获得的结果,以及文献中提到的体内遗传毒性BMR值,我们建议体内诱变终点的BMR为50%。该值可用于解释风险评估背景下的致突变性剂量-反应数据。
{"title":"Benchmark Response (BMR) Values for In Vivo Mutagenicity Endpoints","authors":"Paul A. White,&nbsp;Guangchao Chen,&nbsp;Nikolai Chepelev,&nbsp;Madison A. Bell,&nbsp;Lauren R. Gallant,&nbsp;George E. Johnson,&nbsp;Andreas Zeller,&nbsp;Marc A. Beal,&nbsp;Alexandra S. Long","doi":"10.1002/em.70006","DOIUrl":"10.1002/em.70006","url":null,"abstract":"<p>The benchmark dose (BMD) approach constitutes the most effective and pragmatic strategy for the derivation of a point of departure (PoD) for comparative potency analysis, risk assessment, and regulatory decision-making. There is considerable controversy regarding the most appropriate benchmark response (BMR) for genotoxicity endpoints. This work employed the Slob (2017) Effect Size (ES) theory to define robust BMR values for the in vivo transgenic rodent (TGR) and <i>Pig-a</i> mutagenicity endpoints. An extensive database of dose–response data was prepared and curated; BMD analyses were used to determine endpoint-specific maxima (i.e., parameter <i>c</i>) and within-group variance (i.e., <i>var</i>). Detailed analyses investigated the dependence of <i>var</i> on experimental factors such as tissue, administration route, treatment duration, and post-exposure tissue sampling time. The overall lack of influence of these experimental factors on <i>var</i> permitted the determination of typical values for the endpoints investigated. Typical <i>var</i> for the TGR endpoint is 0.19; the value for the <i>Pig-a</i> endpoint is 0.29. Endpoint-specific <i>var</i> values were used to calculate endpoint-specific BMR values; the values are 47% for TGR and 60% for <i>Pig-a</i>. Endpoint-specific BMR values were also calculated using the trimmed distribution of study-specific standard deviation (SD) values for concurrent controls. Those analyses yielded endpoint-specific BMR values for the TGR and <i>Pig-a</i> endpoints of 33% and 58%, respectively. Considering the results obtained, and the in vivo genetic toxicity BMR values noted in the literature, we recommend a BMR of 50% for in vivo mutagenicity endpoints. The value can be employed to interpret mutagenicity dose–response data in a risk assessment context.</p>","PeriodicalId":11791,"journal":{"name":"Environmental and Molecular Mutagenesis","volume":"66 4","pages":"172-184"},"PeriodicalIF":2.3,"publicationDate":"2025-04-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/em.70006","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143788162","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Environmental and Molecular Mutagenesis
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1